﻿<?xml version="1.0" encoding="utf-8"?><rss version="2.0"><channel><title>OSN Supersite</title><link>http://www.osnsupersite.com/rss.aspx</link><description>The latest news and articles from the OSN Supersite, leading ophthalmology publication on the web.</description><copyright>(c) 2007, Slack Incorporated. All rights reserved.</copyright><ttl>5</ttl><item><title>OSN NY 2011 Video Highlights; Case Studies in Diabetic Macular Edema</title><description /><link>http://www.osnsupersite.com/view.aspx?rid=91023</link><pubDate>Wed, 06 Jun 2012 10:48:00 GMT</pubDate><guid>http://www.osnsupersite.com/view.aspx?rid=91023</guid></item><item><title>OSN EXCLUSIVE: Video presentations from Hawaiian Eye 2012 and Retina 2012</title><description /><link>http://www.osnsupersite.com/view.aspx?rid=92104</link><pubDate>Fri, 03 Feb 2012 12:43:00 GMT</pubDate><guid>http://www.osnsupersite.com/view.aspx?rid=92104</guid></item><item><title>Individualized treatment may be key in managing ocular inflammation after cataract surgery</title><description /><link>http://www.osnsupersite.com/view.aspx?rid=92100</link><pubDate>Fri, 03 Feb 2012 11:03:00 GMT</pubDate><guid>http://www.osnsupersite.com/view.aspx?rid=92100</guid></item><item><title>Medical therapies may be preferred for treatment of ocular surface tumors</title><description /><link>http://www.osnsupersite.com/view.aspx?rid=92099</link><pubDate>Fri, 03 Feb 2012 10:55:00 GMT</pubDate><guid>http://www.osnsupersite.com/view.aspx?rid=92099</guid></item><item><title>Early results for laser-assisted dacryocystorhinostomy may be disappointing, speaker says</title><description /><link>http://www.osnsupersite.com/view.aspx?rid=92098</link><pubDate>Fri, 03 Feb 2012 10:52:00 GMT</pubDate><guid>http://www.osnsupersite.com/view.aspx?rid=92098</guid></item><item><title>Informed consent process for cataract surgery has become more complex, presenter says</title><description /><link>http://www.osnsupersite.com/view.aspx?rid=92097</link><pubDate>Fri, 03 Feb 2012 10:20:00 GMT</pubDate><guid>http://www.osnsupersite.com/view.aspx?rid=92097</guid></item><item><title>Updated dry eye, meibomian gland dysfunction treatment cleared by FDA</title><description /><link>http://www.osnsupersite.com/view.aspx?rid=92095</link><pubDate>Fri, 03 Feb 2012 09:52:00 GMT</pubDate><guid>http://www.osnsupersite.com/view.aspx?rid=92095</guid></item><item><title>Upgrade enables real-time tracking with Optovue OCT</title><description /><link>http://www.osnsupersite.com/view.aspx?rid=92055</link><pubDate>Thu, 02 Feb 2012 11:18:00 GMT</pubDate><guid>http://www.osnsupersite.com/view.aspx?rid=92055</guid></item><item><title>Vitreomacular adhesion treatment to get priority review, ThromboGenics reports</title><description /><link>http://www.osnsupersite.com/view.aspx?rid=92054</link><pubDate>Thu, 02 Feb 2012 11:16:00 GMT</pubDate><guid>http://www.osnsupersite.com/view.aspx?rid=92054</guid></item><item><title>FDA approves phase 1/2 trial of stem cells as dry AMD treatment</title><description /><link>http://www.osnsupersite.com/view.aspx?rid=92053</link><pubDate>Thu, 02 Feb 2012 11:11:00 GMT</pubDate><guid>http://www.osnsupersite.com/view.aspx?rid=92053</guid></item></channel></rss>
